/PRNewswire/ DelveInsight s Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, pancreatic.
Seoul [South Korea], May 12 (ANI/Global Economic): NeoImmuneTech said on the 11th that it has obtained the approval for a phase 2 clinical trial plan that concomitant administration of US Merck s immune checkpoint inhibitor Keytruda and its T-cell amplifier NT-I7 to patients with glioblastoma from the United States Food & Drug Administration (US FDA).